MannKind (MNKD)
(Delayed Data from NSDQ)
$3.75 USD
-0.03 (-0.79%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.75 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
MannKind Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MNKD 3.75 -0.03(-0.79%)
Will MNKD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MNKD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MNKD
AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for
MNKD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates
Compared to Estimates, MannKind (MNKD) Q4 Earnings: A Look at Key Metrics
Other News for MNKD
Earnings week ahead: AMD, PLTR, PFE, DIS, O, ET, SHOP, GILD, MCD, CAT, VTRS, BP, UBER, CGC, and more
MannKind Corp (MNKD) Announces Upcoming Release of Q2 2025 Financial Results | MNKD stock news
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, ...
MannKind (MNKD) Target Price Adjusted by RBC Capital | MNKD Stock News
MannKind (MNKD) Price Target Cut by RBC Capital | MNKD Stock News